Merck & Company (MRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,050,000 | 9,676,000 | 7,965,000 | 6,092,000 | 6,515,000 |
| Marketable Securities | N/A | 774,000 | 899,000 | 2,406,000 | 7,826,000 |
| Receivables | 6,803,000 | 6,778,000 | 7,071,000 | 6,873,000 | 7,018,000 |
| Inventories | 5,554,000 | 5,978,000 | 5,440,000 | 5,096,000 | 4,866,000 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 4,389,000 |
| Other current assets | 7,357,000 | 4,277,000 | 4,500,000 | 4,299,000 | 0 |
| TOTAL | $27,764,000 | $27,483,000 | $25,875,000 | $24,766,000 | $30,614,000 |
| Non-Current Assets | |||||
| PPE Net | 17,000,000 | 15,053,000 | 13,291,000 | 12,439,000 | 12,026,000 |
| Investments And Advances | 785,000 | 1,469,000 | 6,233,000 | 12,125,000 | 11,416,000 |
| Intangibles | 32,983,000 | 33,621,000 | 31,357,000 | 32,467,000 | 35,467,000 |
| Other Non-Current Assets | 13,056,000 | 6,771,000 | 5,881,000 | 6,075,000 | 5,854,000 |
| TOTAL | $63,824,000 | $56,914,000 | $56,762,000 | $63,106,000 | $64,763,000 |
| Total Assets | $91,588,000 | $84,397,000 | $82,637,000 | $87,872,000 | $95,377,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,327,000 | 3,738,000 | 3,318,000 | 3,102,000 | 2,807,000 |
| Accrued Expenses | 12,212,000 | 12,549,000 | 10,151,000 | 10,427,000 | 10,274,000 |
| TOTAL | $27,327,000 | $22,220,000 | $22,206,000 | $18,614,000 | $17,204,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 25,360,000 | 22,736,000 | 19,806,000 | 21,353,000 | 24,274,000 |
| Other Non-Current Liabilities | 12,488,000 | 12,054,000 | 12,068,000 | 11,093,000 | 8,493,000 |
| TOTAL | $38,857,000 | $36,176,000 | $33,549,000 | $34,689,000 | $37,865,000 |
| Total Liabilities | $66,184,000 | $58,396,000 | $55,755,000 | $53,303,000 | $55,069,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,530,316 | 2,536,269 | 2,581,220 | 2,696,190 | 2,745,571 |
| Common Shares | 1,788,000 | 1,788,000 | 1,788,000 | 1,788,000 | 1,788,000 |
| Retained earnings | 47,362,000 | 46,602,000 | 42,579,000 | 41,350,000 | 44,133,000 |
| Other shareholders' equity | -6,547,000 | -6,099,000 | -5,364,000 | -4,677,000 | -5,006,000 |
| TOTAL | $25,404,000 | $26,001,000 | $26,882,000 | $34,569,000 | $40,308,000 |
| Total Liabilities And Equity | $91,588,000 | $84,397,000 | $82,637,000 | $87,872,000 | $95,377,000 |